title: Is autologous stem cell transplantation for transformed follicular lymphoma still justifiable?
authors.affiliation: University of Melbourne, Melbourne, Australia. Michael.Dickinson@petermac.org
authors.forename: Michael
authors.initials: M
authors.lastname: Dickinson
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000473:pathology*; D008297:Male; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab